BIOCRYST PHARMACEUTICALS (EUROPEAN ORLADEYO BEROTRALSTAT BUSINESS)
Summary
ORLADEYO (berotralstat) is a medication manufactured by BioCryst Pharmaceuticals for the prophylactic treatment of hereditary angioedema (HAE).
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 192 M
Avg. Deal Size£ 192 M
All rights reserved. Copyright © 2026 Datasite